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Abstract
This chapter contains three parts covering recent efforts to increase the accuracy of opti-
cal coherence tomography (OCT) differential diagnostics of bladder pathologies. The first 
part compares the diagnostic efficacy of traditional OCT and cross-polarization OCT (CP 
OCT); CP OCT and fluorescence cystoscopy (FC) for detecting flat lesions in the bladder 
at the early stages of cancer. The second part contains a report on achievements in appli-
cation of CP OCT for detection of recurrent carcinoma in the scar area that is a hardly 
distinguishable form of bladder cancer using an optimized CP OCT image analysis. The 
third part of the chapter reviews the results on CP OCT usage for in vivo diagnosis of the 
bladder cancer after radiation therapy of cervical cancer.
Keywords: cross-polarization optical coherence tomography (CP OCT), bladder cancer, 
collagen, laser scanning microscopy (LSM), radiation damage
1. Introduction
Bladder cancer can manifest in a variety of different forms, and chronic inflammation plays 
the key role in its development [1]. One of the origins of bladder cancer development is the 
side-effect of radiation therapy. The radiation therapy of the uterus or prostate cancer fre-
quently induces substantial alterations in the bladder wall that may progress to bladder can-
cer. Such side-effects of the radiation therapy of pelvic organs are of particular interest, as 
they occur in the patients with predicted long life expectancy, and preservation of the life 
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quality is of comparable importance with recurrence prevention [2]. In this situation, early 
detection of bladder cancer or pre-cancer manifestations, preferably non-invasive, is the key 
for timely treatment.
Traditionally, white-light cystoscopy is employed for detection of bladder cancer. Besides the 
invasiveness and potential risks, white light cystoscopy drawbacks include difficult detection 
of flat lesions, inaccurate tumor delineation, which leads to complete resection and inability 
to differentiate between inflammation and malignancy and to determine the tumor grade 
and stage. In clinical practice, the overcoming of these drawbacks strongly depends on the 
surgeon’s experience [3].
In the last decade, the techniques for diagnosing bladder pathologies were complemented by 
optical coherence tomography (OCT) being actively introduced into clinical practice [4–6]. 
OCT is a modern optical non-invasive imaging technique based on the principles of reflec-
tance low-coherence interferometry, which can provide a tissue image to the depths up to 
several millimeters with spatial resolution down to units of μm. Cross-polarization OCT (CP 
OCT) is an OCT modality where probing is performed by polarized light; and two conjugated 
images are being registered in the channels with polarization parallel and orthogonal to initial 
one (co- and cross-polarization channels, respectively).
Many OCT research groups develop their own approaches for differential diagnostic of early 
bladder cancer [3, 7, 8]. The combination of OCT diagnostics with image analysis and sig-
nal processing (e.g., histograms analysis [9, 10], extraction of optical properties [11], texture 
analysis [12, 13]) has a high potential for automated differential diagnostics. To bridge the gap 
between research and clinical use, the potential of CP OCT was systematically investigated for 
real-time and label-free imaging. Nowadays, the studies are focused on challenging problems 
such as hardly distinguishable forms of bladder disorders related with cancer. Alterations in 
normal tissue that occur in the early and late periods after radiation therapy are an actual prob-
lem of modern radiation oncology [14] where high potential of the CP OCT was demonstrated.
This chapter contains three parts covering recent efforts to increase the accuracy of OCT dif-
ferential diagnostics of bladder pathologies. The first part compares the diagnostic efficacy of 
traditional OCT (equivalent to obtaining co-polarized image only), CP OCT (employing com-
bination of cross-polarized and co-polarized images), and fluorescence cystoscopy (FC) for 
detecting flat lesions in the bladder at early stages of cancer. In the second part, we report on the 
recent achievements in application of CP OCT for detection of carcinoma recurrence in scar area 
using an optimized CP OCT image analysis/quantification platform. The platform is based on 
detecting alterations in the collagen compartment of interrogated tissue’s extra-cellular matrix 
(ECM). The third part reviews the pilot results of CP OCT employment for in vivo evaluation 
of the severity of the bladder mucosa damage after radiation therapy of cervical cancer. In addi-
tion to morphological analysis with hematoxylin and eosin (H&E) and picrosirius red (PSR) 
staining, nonlinear laser scanning microscopy (LSM) study was performed to confirm the level 
of collagen damage and remodeling as a consequence of cancer invasion and radiation therapy.
CP OCT studies of human urinary bladder mucosa during in vivo endoscopic examination 
described in this chapter were performed with the “OCT 1300-U” system (IAP RAS, Nizhny 
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Novgorod, Russia). CP OCT device has a forward-looking (en-face) endoscopic probe with 
outer diameter 2.7 mm that is placed vertically to the mucous surface leaving an imprint on it, 
so the tissue is taken for histology from the same area and has the same orientation. The CP 
OCT system is based on superluminiscent diode with central wavelength 1300- and 100-nm 
bandwidth and has axial resolution ~15 μm and lateral resolution ~25 μm. Using the circu-
lar polarized probing light and two signal acquisition channels to detect scattered light that 
maintained initial polarization and change it to orthogonal one gave an advantage to assess 
co- (“co-polarized image”) and cross-scattering (“cross-polarized image”) properties of the tis-
sue up to 1.8 mm in depth. CP OCT image size is 2.5 × 4.0 mm (width × height), image acquisi-
tion rate is 0.5 frames per sec. Refer to previous publications [15, 16] for more detailed system 
descriptions, including the optical phase retardation particulars to enable CP operation.
The fragments of the bladder mucosa from the sites of CP OCT inspection extracted in course of 
surgery and biopsy were subjects for further histological and LSM examination. Later, CP OCT 
images were compared to the morphological images. Histologic study included light microscopy 
with H&E staining and polarized light transmission microscopy with PSR staining for evaluation 
of structural and spatial organization of collagen fibers; LSM was applied in second harmonic 
generation (SHG) mode with excitation at the wavelength of 800 nm and spectral detection in the 
range of 362–415 nm to reveal the distribution of collagen fibers in the bladder mucosa.
The Ethics Committee of Nizhny Novgorod State Medical Academy for scientific research 
involving human subjects approved the clinical study. All patients voluntarily signed the 
informed consent for the study.
2. Efficacy of cross-polarization OCT in bladder cancer diagnosis: 
comparison with traditional OCT, fluorescence cystoscopy, and 
immunohistochemical study
The early OCT studies of bladder mucosa were performed with traditional time-domain 
modality equipped with an endoscopic probe. Diagnosis of early bladder cancer was the 
central topic of OCT studies in urology [4]. After 25 years, the OCT technique significantly 
improved resulting, in particular in cross-polarization time-domain OCT with common-path 
optical layout and two signal acquisition channels and in spectral CP OCT modification with 
the similar characteristics enabling 3D imaging.
2.1. Cross-polarization OCT and traditional OCT at bladder cancer
In course of introduction of CP OCT into clinical practice, the capabilities of this new tech-
nique for early bladder cancer detection were assessed in a comparative study with the 
traditional OCT. To assess the efficacy, the special test was developed. It consisted of two 
independent stages: assessing diagnostic capabilities of OCT (using a set of co-polarized 
images) for detecting neoplasia and assessing diagnostic capabilities of CP OCT (using a 
set of the same clinical cases, but with two images: in co- and in cross-polarization) for the 
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same task. Statistical evaluation of the diagnostic efficacies of OCT and CP OCT was also 
performed independently. A total of 116 patients with localized flat suspicious lesions in the 
bladder were enrolled, 360 CP OCT images were acquired and analyzed. Statistical param-
eters and general results of the blind recognition tests of CP OCT and OCT images of flat 
suspicious lesions in the bladder are listed in Ref. [17].
Briefly, it was shown that CP OCT demonstrated higher sensitivity of 93.7% (vs. 81.2%, p 
< 0.0001), specificity 84% (vs. 70.0%, p < 0.001), and diagnostic accuracy 85.3% (vs. 71.5%, 
<0.001) in detecting early malignant changes in flat suspicious zones compared to the tra-
ditional OCT technique. The interobserver agreement index kappa increased from 0.68 to 
0.82 when images in cross-polarization were added. The earlier analysis of more than 500 
traditional OCT [4] and CP OCT images of benign and malignant states of the bladder [18] 
enabled us to formulate visual criteria for assessing CP OCT images in co- and in cross-
polarization (Table 1).
Higher diagnostic efficacy of CP OCT in detecting early bladder cancer is associated with the 
ability to detect changes in epithelium and connective tissues. In previous works (see Refs. 
[17, 19]), it was demonstrated that OCT signal in cross-polarization (Figure 1a, upper image) 
is formed primarily due to cross-scattering from unaltered, well-organized type I collagen. 
This statement is based on the comparison of the signal level in cross-polarization with the 
brightness of PSR-stained collagen fiber luminescence in polarized light (Figure 1j).
It is known that collagen stained with PSR and examined with polarized light microscopy 
reveals its birefringent properties, visualized as bright pixels against the background of dark 
surrounding tissue elements (reference). Collagen type I has red and red-yellow color (thick 
fibers with thickness ~2–5 μm and higher) and collagen type III—green and green-white color 
(thin fibers with thickness ~1 μm). Red-orange color of thick-collagen fibers is also associated 
with densely packed collagen fibers indicative of their maturity [20].
CP OCT image characteristics Benign processes in  
the bladder
Malignant processes in the 
bladder
In co-polarization: OCT features Sharp, high contrast 
between epithelium and 
connective tissue in more 
than 75% of the lateral 
range of image. The 
epithelial layer has lower 
signal level than  
the connective tissue layer
No or weak contrast 
between horizontal layers
OCT type images Benign Cancer
In cross-polarization: OCT features Uniform signal that may 
have the structure of 
horizontal layers
No or weak signal, in 
some images in the form of 
isolated spots
OCT type images Benign Cancer
Table 1. Visual criteria for assessing CP OCT images in co- and in cross-polarizations.
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The loss of collagen polarization properties due to its disorganization at neoplasia 
(Figure 1f and i) and massive inflammatory cellular infiltration significantly reduces 
OCT signal level in cross-polarization (Figure 1c, upper image). At the same time, CP 
OCT images at chronic cystitis in cross-polarization have regions with high-level signal 
(Figure 1b). It is caused by diffuse excessive synthesis and accumulation of collagen fibers 
(its assembly/bunching in the background of reduced degradation), especially around ves-
sels (sclerosis of vessel wall; Figure 1e and h).
Figure 1. Bladder mucosa in normal state and in pathology. Normal (a, d, j), chronic exudative cystitis (b, e, h) and 
urothelial carcinoma Ia (c, f, i). CP OCT images (upper panel = cross-polarization, lower panel = co-polarization) (a, b, 
c), the corresponding histological slides stained with hematoxylin and eosin was used to confirm the diagnosis (d, e, f), 
stained with picrosirius red and examined with polarized light—to reveal the presence and type of collagen (j, h, i). U—
urothelium, CT—connective tissue, M—muscle, V—vessel, UC—urothelial carcinoma.
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Based on the qualitative considerations above, it appears that morphological and polariza-
tion changes of collagen fibers properties in various pathological states are complex and 
interrelated.
2.2. Cross-polarization OCT, fluorescence cystoscopy, and immunohistochemical study at 
bladder cancer
Fluorescence cystoscopy (FC) is one of the techniques to search for regions suspicious for 
cancer on the inner bladder surface. However, it has low-positive predictive value [21, 22]. 
Immunohistochemical (IHC) markers for bladder cancer Ta-T2a have potential to improve 
the diagnostics and help in understanding of carcinogenesis at molecular level [23]. 
Unfortunately, this technique can be employed only ex vivo. Recent studies of years [19] 
were aimed to assess the diagnostic accuracy of the combined use of FC and CP OCT with 
quantitative estimation of OCT signal in cross-polarization for diagnosis of superficial blad-
der cancer in flat suspicious lesions and analyze epithelial and carcinoma cells proliferation 
activity by using IHC markers. A total of 26 patients with bladder cancer were enrolled in 
the study. Total amount of regions of interest was 92; 41 sites with urothelial carcinoma (28 
cases of cancer in bladder tissue/13 cases of recurrent cancer in scar tissue) and 51 sites with 
inflammation (16 mild/35 severe).
The results of the study show that the combined use of FC and CP OCT with quantitative 
estimation of the OCT signal yields the diagnostic accuracy in detecting bladder cancer in flat 
suspicious zones of 93.6%, the sensitivity of 96.4%, specificity of 92.1%, positive predictive 
value of 87%, and negative predictive value of 97.9%, which indicates that the efficacy of this 
approach is close to that of biopsy.
Since chronic inflammation in the bladder is manifested by the increased proliferative 
activity of uroteliocytes, IHC study using cell proliferation markers (Ki-67, p53, and p63) 
allows for more accurate quantification of the urothelium state and the risk of developing 
urothelial neoplasm. Ki-67, p53, and p63 immunohistochemistry is suggested to be helpful 
to distinguish dysplastic changes and carcinoma in situ from reactive atypia. These IHC 
markers were applied for the study of areas where CP OCT images can be classified as 
cancer type.
The IHC study demonstrated a high level of p53 expression and high proliferation activ-
ity (the number of the cells positively stained for Ki-67, p53, and p63 exceeded 50%) in the 
regions of bladder cancer. Those indices were significantly higher (p < 0.0001) comparing to 
the regions with severe inflammation. In the regions with mild inflammation, the level of 
Ki-67, p53, and p63 did not differ significantly (p > 0.05) from those with severe inflammation 
[23]. This confirms that the increased urothelium proliferation level in patients with bladder 
cancer is typical for the entire mucosa and does not depend on the visual manifestations of 
the inflammatory process [1, 24].
The expression of p63 only in the areas of red fluorescence was significantly higher (p = 0.038) than 
in the areas without fluorescence. The expression of Ki-67 and p53 did not depend on fluorescence.
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The study confirms enhanced expression of p53, p63, and Кi-67 in patients with recurrent, 
highly differentiated superficial (without invasion into the muscular layer) urothelial carci-
noma with a low or moderate risk of disease progression [25–28].
Also, a correlation between CP OCT data and IHC markers data was demonstrated. High 
inverse correlation (r = −0.732; r = −0.647 and r = −0.481, respectively, p < 0.002) was demon-
strated between the expression of p63, Ki-67, and p53 markers and the CP OCT signal in cross-
polarization. The obtained correlations allow suggesting why signal in cross-polarization 
alters in cases of inflammation and neoplasia. Healthy tissue in co-polarization has a layered 
structure featuring the epithelium and connective stroma. A neoplastic process characterized 
by excessive proliferation of urothelial cells losing specificity is accompanied by activation of 
p53, p63, and Ki-67 expression. On the one hand, active proliferation can change optical prop-
erties of epithelial cells; on the other hand, it eventually leads to disorganization of collagen 
matrix. It was found that the higher the expression of the markers of cellular proliferation and 
adherence, the more intense loss of cross-scattering properties by connective tissue collagen is 
registered by CP OCT. However, it is still unclear which process is primary.
3. CP OCT for diagnostics of recurrent bladder cancer
Recurrent forms of bladder cancer are hard to distinguish by routine diagnostic approaches 
(cystoscopy). In the majority of cases, cancer recurrence at scar is hard to be distinguished 
from the scar tissue. In this situation, even OCT inspection may fail to provide adequate infor-
mation due to visual similarity of scar and cancer in a diagnostic OCT image.
To develop an approach to distinguish the recurrence of bladder cancer and the scar, parallel 
in vivo CP OCT and morphological study of the level of cross scattering and state of collagen 
was performed for scar tissue (group 1, n = 30) and carcinoma in the scar area (group 2, n = 28). 
Figure 2 shows that sometimes CP OCT images in the scar tissue (a) and in recurrence of carci-
noma in scar area (d) look quite similar. In cross-polarization, the OCT signal is heterogeneous: 
in both cases, there are areas with high, reduced, or absence of signal (Figure 2a and d, upper 
images). Analysis of the structural organization of collagen fibers at fiber and tissue levels 
in the scar tissue (group 1) showed that in condition of chronic inflammation of the bladder 
mucosa areas of excessive synthesis and accumulation of collagen (see Figure 2, red and yel-
low color on PSR image (b) and intense green color on SGH image (c)) might alternate with not 
yet formed collagen fibers areas (see Figure 2, pale green color or dark areas on PSR image (b) 
and week or no SHG signal (c)). Analysis of the recurrence of carcinoma on a post-operation 
scar region (Group 2) revealed that on PSR image areas of carcinoma are dark, and collagen 
fibers are thin of pale-red color (Figure 2e); some of collagen fibers are destroyed. The collagen 
fibers are loosely stacked and surround cancer cells in SGH image (Figure 2f).
OCT image processing and quantification may give an additional valuable information for 
differentiation these two conditions. A number of previous studies demonstrate that the 
changes in polarization properties correlate with changes in collagen state [6, 23, 29–31] while 
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orientation and the degree of structural organization of collagen at fiber and tissue levels 
allowed to conclude on the presence of pathology [30]. Quantitative processing of CP OCT 
images was based on analysis of the cross-scattering properties of the bladder tissue [6]. An 
integral depolarization factor (IDF) was developed and successfully applied to quantify the 
collagen state within tissue [31]. IDF is defined as a ratio of the OCT signals in cross-polariza-
tion to co-polarization, both averaged over the transverse coordinates.
The results of comparing IDF in the groups of scar tissue (Group 1) and recurrence of urothelial 
carcinoma in the scar region (Group 2) are presented in Figure 2j. A statistically significant dif-
ference in IDF values between these two conditions is demonstrated (p < 0.0001), which testifies 
to the possibility of effective cystoscopic recognition of carcinoma in the region of post-opera-
tion scar with the IDF/CP OCT platform. It is known that collagen fibers are destroyed under 
the influence of tumor cell enzymes [32]; this likely decreased the resultant cross-polarization 
OCT signal. The quantitative assessment of CP OCT images obtained from the suspicious areas 
of postoperation scars can thus help in distinguishing the appearance of tumor in scar region.
Sensitivity, specificity, and diagnostic accuracy of separating recurrence of carcinoma in 
region of the bladder scar by quantitative assessment of CP OCT images with IDF are 93, 99, 
and 97%, respectively.
Figure 2. Scar tissue on the bladder mucosa and recurrence of urothelial carcinoma in the scar region. Group 1 (the upper 
row of images and left column on the diagram), Group 2—recurrence of carcinoma in the scar region (the lower row and 
left column on the diagram). CP OCT images (upper panel = orthogonal polarization, lower panel = initial polarization) 
(a, d); corresponding histological slides stained with picrosirius red and examined with polarized light (b, e); SHG 
images (c, f). ST—scar tissue, UC—urothelial carcinoma.
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Intraoperative CP OCT monitoring of completeness of tumor removal was introduced into clini-
cal practice (N.A. Semashko Nizhny Novgorod Regional Hospital) allowing minimizing the 
number of cancer recurrences at postoperative scar regions.
4. CP OCT for in vivo detection of bladder cancer after radiation therapy
The third paragraph of the chapter reviews the pilot results on CP OCT employment for in 
vivo detection of the bladder cancer after radiation therapy of cervical cancer.
Bladder cancer that occurs after radiation therapy of malignant neoplasms of the pelvic organs 
is a special problem in clinical urology. According to European Association of Urology, there 
is a two- to four-fold increase in the risk of secondary malignant tumors development in the 
bladder after radiotherapy of tumors of pelvic organs [33]. Recent studies [34, 35] confirmed 
the increase in the risk of bladder cancer for 1.5–4 times after the course of radiotherapy.
Alterations of normal bladder tissue occurring in the early and late periods after radio-
therapy are an unsolved problem in modern radiation oncology [36]. The early side-effects 
include changes developed in the course of radiotherapy and 100 days after it. Radiation 
damages that appear after 3 months since radiotherapy procedure are treated as late; some-
times, they may occur in years after irradiation. In addition, in recent years, late effects 
resulting from long-term persistent severe acute radiation damage called “consequential late 
effects” are distinguished separately [37]. Specifically, late radiation-induced adverse events 
are of significant clinical importance [14]. Their severity can vary from clinically insignificant 
structural abnormalities to severe complications that have a great impact on the quality of 
patient’s life (Cancer Therapy Evaluation Program) [38]. Different classifications including 
CTCAE, RTOG/EORTC, RILIT, and LENTSOMA were employed to determine the sever-
ity of post-radiation damage to normal tissues. Currently, the classification developed by 
Radiotherapy Oncology Group in collaboration with the European Organization for Research 
and Treatment of Cancer (RTOG/EORTC, 1995) is the most common classification scale for 
radiation complications (Table 2).
When bladder cancer appears in the irradiated and altered tissues, it becomes extremely diffi-
cult to diagnose cancer against edema, hemorrhage, and pronounced changes in the mucosa. 
Therefore, there is a challenge to differentiate changes induced by ionizing radiation and the 
changes caused by the tumor growth by standard clinical methods. In this situation, optical 
diagnostic techniques can play a crucial role in establishing the correct diagnosis.
In our clinical practice during last 2 years, a situation where CP OCT inspection allowed to 
diagnose bladder cancer in patients previously received radiotherapy for cervical cancer was 
met twice. Both patients have tumors developed at the background of severe (Grades 3 and 4) 
late side-effects of radiotherapy (Table 2).
Patient T., 65 years old, was hospitalized in urology department for vesico-urinary fistula. 
In January 2014, she was diagnosed with cervical cancer T3N0M0 (stage III). She received a 
concurrent chemoradiation therapy (external beam irradiation in a dose of 40 Gy, single dose 
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2 Gy), brachytherapy in a dose of 25 Gy, single dose 5 Gy). In 18 months after radiation ther-
apy, urine outflow from the vagina and blood in urine appeared. Ultrasound study revealed 
serozometra and right-side hydronephrosis. Laboratory blood tests showed signs of kidney 
failure. The right-side nephrostomy under ultrasound control and optical inspection of the 
bladder was made in November 2015. Cystoscopy revealed an organized blood clot within 
the bladder cavity. After bladder cavity dilatation, it was found that the bladder bottom was 
absent resulting in, a fistula defect of 3.5–4.0 cm in diameter. Bullous fabric with disintegra-
tion was revealed at the edge of the fistula. Mucosa of the bladder walls was hyperemic and 
hydropic (Figure 3a). Ureteral orifices were not visualized. Therefore, cystoscopy picture was 
consistent with the picture of Grade 4 radiation bladder damage (fistula, bleeding).
At the same time, bladder mucosa was studied with CP OCT; images of back left and right 
walls and around the fistula defect were acquired. CP OCT image of the back wall (Figure 3c) 
demonstrates the classic picture of chronic inflammation. Despite contrasted layers in co-
polarization and high-level signal from connective tissue fibrosis in cross-polarization, both 
images feature edema (dark elongated areas, which have vertical shadows) and homoge-
neous areas originating from inflammatory cell infiltration of the stroma.
CP OCT image of the fistula edge (Figure 3b) manifests bullous features: in co-polarization, 
the image is mostly structureless: only the small area of image in the left has layers of 
epithelium (the first layer, may be with dysplastic changes), underlying connective tissue 
(the second layer, brighter) and below the signal abruptly falls (this area is suspicious to 
cancer); the central and the right side of the image are structureless, indicating neoplasia 
(Figure 3b). In cross-polarization, there is no pronounced signal, which approves the pres-
ence of neoplasia, and only small area in left side of the image corresponding to connec-
tive tissue demonstrates low-level signal. This flat zone is the suspicious area of the CP 
OCT image and transurethral biopsy was taken from this site. Morphologically, invasive 
Organ tissue Bladder
Grade 0 None
Grade 1 Slight epithelial atrophy, minor telangiectasia  
(microscopic hematuria)
Grade 2 Moderate frequency
Generalized telangiectasia
Intermittent macroscopic hematuria
Grade 3 Severe frequency and dysuria
Severe generalized telangiectasia (often with petechiae)
Frequent hematuria
Reduction in bladder capacity (<150 cc)
Grade 4 Necrosis/contracted bladder (capacity <100 cc)
Severe hemorrhagic cystitis
Grade 5 Death directly related to radiation late effects
Table 2. Classification of late radiation bladder damage (RTOG/EORTC, 1995).
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 transitional cell carcinoma Grade 2 was diagnosed (Figure 3b4). Conglomerates of cancer 
cells grow into the mucosa and submucosa layers of the bladder wall (area with low signal 
in co- and dark area in cross-polarization in Figure 3b, border of connective tissue is indi-
cated with blue arrow). Carcinoma cells were localized deeper in connective tissue at the 
one side, whereas at the other side, it starts from the surface. Owing to CP OCT, biopsy was 
performed and urothelial carcinoma Grade 2 was detected while visually this area looked 
like inflammation.
We suppose that radiation induced damage of bladder connective tissue induced carcinoma 
development. In cross-polarization (left side of image), a low level signal from connective 
tissue is observed, originating from exudative inflammation process. Morphological analysis 
Figure 3. CP OCT guided biopsy of bladder mucosa and LSM study of extracellular matrix in 18 months after the end of 
radiation therapy. Cystoscopy image of the back wall in a moment of CP OCT study (a), CP OCT images (upper panel 
= cross-polarization, lower panel = co-polarization): image of tissue suspicious to cancer from border of fistula b), image 
of benign tissue from the back wall (c), LSM images (SHG (b1), 2PEF (b2) and combined SHG-2PEF (b3)) and histology 
(H&E) (b4) corresponding to CP OCT image (b). CT—connective tissue; U—urothelium; UC—urothelial carcinoma; 
arrows indicate border of carcinoma growth; yellow rectangle in (b) indicates area of LSM imaging (b1–b3).
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revealed congestion, swelling, lymphoid cell infiltrates in mucosa, and, important to mention, 
degenerative changes in collagen that cause decrease in cross-polarization OCT signal.
In order to determine more accurately the condition of collagen and elastic fibers in connec-
tive tissue of mucosa layer multiphoton, microscopy study was conducted. Confocal laser 
scanning microscope (LSM 710, Carl Zeiss, Germany) was used at the excitation wavelength 
of 800 nm. Detection was performed simultaneously in two channels by using filters in the 
wavelength ranges of 362−415 nm and 480−554 nm, with the aim to detect signals indicating 
SHG emission (green color in the images) and 2PEF emission (red color in the images), respec-
tively. This approach allowed visualization of the collagen (seen in SHG) and primary elastin 
(seen in 2PEF) fibers in the walls of the bladder within the unstained, dewaxed sections with 
a thickness of 10 μm.
Two LSM images were combined to demonstrate the boundary between urothelial carcinoma 
and connective tissue (Figure 3b1–b3, the boundary is indicated with black arrow). Numerous 
small holes in the connective tissue corresponded to inflammatory infiltration, collagen is pri-
mary disorganized and looks homogeneous without clearly distinguished fibers (Figure 3b1), 
and elastic fibers are also damaged: they produced weak signal and are presented by frag-
ments in a small amount (Figure 3b2). LSM study confirms that the connective tissue of the 
bladder after radiation therapy of pelvic organs has destructive changes that are preserved 
for the long time after treatment and in conjunction with chronic inflammation such condition 
can serve as a background for the cancer development.
Patient N., 41 years old, was urgently hospitalized in urology department with the diagno-
sis of chronic urinary retention. In 2014, she was diagnosed with cervical cancer T2bN0M0 
(stage II), concurrent chemoradiation therapy (external beam irradiation in a dose of 40 Gy, 
brachytherapy in a dose of 25 Gy, single dose of 5 Gy) was held. In 20 months after the end of 
chemoradiotherapy, the patient became complaining of difficulty in urinating.
An ultrasound revealed pelvic adhesions, as well as the fact of bladder atony. Trocar cystos-
tomy and cystoscopy study was done. Cystoscopically (Figure 4a), the mucous membrane 
of the bladder was shiny, whitish, trabecular, with tissue granulation on the back wall and 
in the triangle area; the bladder neck is loose, with a rough surface. Visually, three areas on 
mucosa were suspicious: in the center of the neck, in the neck close to the right wall, and close 
to the back wall. The CP OCT study of these areas was conducted, and then three biopsies 
were taken. Histology revealed presence of urothelial carcinoma Grade 3 complexes in two 
locations: in the center of the neck and in the neck close to the right wall (Figure 4b4 and c4), 
where suspicious type of CP OCT images was obtained (Figure 4b and c). Both images have 
some features are not common for benign states. They contain structureless low signal areas 
without clear borders in co- and cross-polarizations at the lower part of the mucosa layer 
(first layer with a high level signal), and there is no epithelium layer usually manifested by 
middle intensity signal above the mucosa layer. Moreover, OCT signal from connective tissue 
in cross-polarization is homogeneous, whereas in norm and inflammation state, an image 
shows more or less distinct horizontally orientated structures.
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Figure 4. CP OCT of suspicious areas of bladder mucosa and LSM study of extracellular matrix in 20 months after the 
end of radiation therapy. Cystoscopy image of bladder neck with a loop of resectoscope at the time of biopsy (a), CP 
OCT images (upper panel = cross-polarization, lower panel = co-polarization): image of suspicious tissue at the bladder 
neck (b), image of suspicious tissue at the right wall close to the neck (c), image of bening tissue at the back wall (d), 
LSM images (SHG (b1, c1, d1), 2PEF (b2, c2, d2) and combined SHG-2PEF (b3, c3, d3)) and histology (H&E) (b4, c4, 
d4) corresponding to CP OCT images (b, c, d). CT—connective tissue; SA—suspicious area; UC—urothelial carcinoma; 
arrows indicate borders of carcinoma growth; black rectangle in (b, c, d) indicates area of LSM imaging (b1–b3, c1–c3, 
d1–d3, correspondingly).
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CP OCT image of the third visually suspicious area (bladder neck close to the back wall) dem-
onstrates the picture of chronic inflammation (Figure 4d) described above. Histology con-
firms supposed diagnosis: edemas, acute plethora, and round cells infiltration in the mucosa 
were present (Figure 4d4).
LSM images of bladder wall for the patient N. revealed that predominant amount of the fibers 
produces homogeneous signal similar to the previous case (Figure 4c1–c3 and d1–d3). Only 
a few individual fibers of collagen and elastin are distinguished. This indicates disorganiza-
tion processes in extracellular matrix. Loose network and holes in connective tissue in LSM 
images correspond to morphologically verified inflammation: edema and round a (Figure 4c4 
and d4).
Urothelial carcinoma in LSM images looks different: in the bladder neck, collagen in carcinoma 
is not organized (homogeneous SHG signal, Figure 4b1); however, close to the tumor, colla-
gen fibers are straight, densely arranged, and have a prevailing orientation. This may point to 
aggressive and long-time growth of the carcinoma that starts to produce its own stroma and 
change the environment around to facilitate the invasion [32, 39]. In the neck close to the right 
wall, the carcinoma contains no elastic fibers and minimal amount of collagen organized in 
thin wavy fibers like in surrounding connective tissue, what may indicate infiltrative dissemi-
nation of carcinoma cells into loosely packed extracellular matrix (Figure 4c1–c3).
The described clinical cases show that extracellular matrix of bladder mucosa after radiation 
therapy of pelvic organs manifests dystrophic changes that could originate from the side-
effects of radiation exposure and subsequent chronic inflammation. Rate of the bladder syn-
chronic cancer in this case is up to 1.5–4 times larger as compared to nonirradiated bladder 
[34]. We suppose that disorganized collagen and elastic network in mucosa could also pro-
mote carcinoma fast growth and facilitate its invasion.
These examples demonstrate that to the patients, who undergone radiation therapy, a special 
attention and monitoring in the follow-up are required to prevent possible development of 
radiation induced urothelial carcinoma or detects it as early as possible. In this situation, CP 
OCT is an excellent minimally invasive tool for bladder mucosa inspection and evaluation of 
connective tissue state based on data in cross-polarization.
5. Conclusions
This chapter highlighted a novel diagnostic method, CP OCT, with high potential application 
for bladder pathology diagnosis. CP OCT can be considered an effective complementary in 
vivo technique to assess flat suspicious lesions in the bladder initially detected by white light 
or/and fluorescence cystoscopy, whereas the efficacy of these cystoscopy modalities alone or 
combined with traditional OCT is much lower.
Analysis and quantitative assessment of CP OCT images confirmed the presence of cross-
scattering properties of connective tissue stroma in human mucosa that are determined by 
well-defined spatial and structural organization of collagen matrix. Collagen fibers undergo 
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significant changes as a result of pathological processes which affect their cross-scattering 
properties that can be detected and quantified in vivo with CP OCT.
An approach to quantitative, robust, and potentially automated assessment of CP OCT 
images reflecting the state of bladder collagen fibers was developed. It was shown that 
IDF can be applied to in vivo detection of clinically relevant pathological states in urology. 
Differentiating between carcinoma recurrence at post-operation scar and tumor-free scar 
resulted in diagnostic accuracy of 97%. Thus, CP OCT and IDF quantification have promis-
ing potential to visualize and quantify the structural and spatial organization of CF in blad-
der tissues for clinical disease assessment including differential diagnosis applications.
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